Create a free account to unlock these features!
Create a free account to unlock these features!
| Overview | News | Financials | People | Insider Trades | Compensation | Holdings | Ownership | Corporate Family |
| Name: | Abbott Laboratories |
| Industries: | Biotech |
| Revenue: | $30.76B ¹ |
| Profit: | $5.75B ¹ |
| Employees: | 69,000 |
| Headquarters: | 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK, Illinois 60064-3500 United States Of America |
| Website: | |
| Lists: |
| #44 | Highest Market Cap |
| #172 | Worst Performers |
| #11 | Worst Performers In Biotech |
Abbott Labs tries to Ensure good health. Abbott Laboratories (NYSE: ABT) is based in Abbott Park, IL. The company deals with a broad and diversified line of healthcare products. Its primary business segments are Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products, which produce a broad line of adult and pediatric pharmaceuticals and nutritional products; diagnostic systems and tests; surgical devices; acute care injectable drugs; and others. Founded in 1888,
Abbott Labs tries to Ensure good health. Abbott Laboratories (NYSE: ABT) is based in Abbott Park, IL. The company deals with a broad and diversified line of healthcare products. Its primary business segments are Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products, which produce a broad line of adult and pediatric pharmaceuticals and nutritional products; diagnostic systems and tests; surgical devices; acute care injectable drugs; and others. Founded in 1888, the company had 2008 revenue of about $29.5 billion and has about 69,000 employees. In February 2009, it completed its acquisition of Advanced Medical Optics which is now a wholly owned subsidiary of Abbott and has been renamed Abbott Medical Optics Inc.
|
4 hours: |
Bull & amp; Lifshitz, LLP Announces Investigation of the
...
|
|
|
|
4 hours: |
Biotech Stocks: Abbott, Pfizer lead drug stocks lower
|
|
|
|
5 hours: |
Morning Movers: Citi Retreats, S&P Off on Consumer Sentiment
|
|
|
|
6 hours: |
Abbott leads drugs stocks lower
|
|
|
|
10 hours: |
Why I Sold Walgreen and Bought Abbott
|
|
|
|
15 hours: |
Walgreen (WAG) And Abbott Laboratories (ABT): Trading Transparency
|
|
|
|
16 hours: |
Walgreen (WAG) and Abbott Laboratories (ABT) "Trading Transparency"
|
|
|
|
23 hours: |
Abbott agrees to acquire Facet Biotech for USD450m
|
|
|
|
3/11/10: |
Investing in the Biotechnology Industry
|
|
|
|
3/10/10: |
Abbott gets FDA approval for lens implant
|
|
| Income (in thousands of USD) |
3 months ending 2009-12-31 |
12 months ending 2009-12-31 |
| Revenue | 8,790,127 | 30,764,707 |
| Net Income | 4,169,191 | 5,745,838 |
| Balance Sheet (in thousands of USD) | ||
| Current Assets | 23,313,891 | 23,313,891 |
| Total Assets | 52,416,623 | 52,416,623 |
| Current Liabilities | 13,049,489 | 13,049,489 |
| Total Liabilities | 29,560,996 | 29,560,996 |
| Total Shareholders Equity | 22,855,627 | 22,855,627 |
| Cash Flow (in thousands of USD) | ||
| Cash from Operating Activity | 1,832,617 | 7,275,160 |
| Cash from Investing Activity | 1,562,877 | -3,698,710 |
| Cash from Financing Activity | 503,373 | 1,002,019 |
| Change in Cash | 3,933,424 | 4,697,317 |
| Key Stats |
3 months ending 2009-12-31 |
Trailing 12 Months |
| Gross Profit Margin | 56.95% | 57.06% |
| Net Profit Margin | 47.43% | 18.68% |
| Return on Assets | 7.95% | 10.96% |
| Return on Equity | 18.24% | 25.14% |
| Return on Invested Capital | 4.42% | 13.39% |
